Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel

Page 6 of 14

Page 6 of 14 – SEC Filing
CUSIP No.
761299106
1.
NAME OF REPORTING PERSONS:  Matthew Sirovich
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
8,750
6.
SHARED VOTING POWER
3,598,222
7.
SOLE DISPOSITIVE POWER
8,750
8.
SHARED DISPOSITIVE POWER
3,598,222
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,606,972
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.88%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 6 of 14